July
Bone loss prevention experiment on the last space shuttle flight
Researchers in the University of North Carolina at Chapel Hill/North Carolina State University joint biomedical engineering department will be at the Kennedy Space Center for the last space shuttle launch of the NASA program as Atlantis departs for its final mission into Earth’s orbit.
Second round of Health-e-NC pilot projects funded statewide
Five new projects have been funded under the second round of Health-e- NC (Health for Everyone in North Carolina) grants program. The program provides pilot funding in support of the University Cancer Research Fund’s strategic goal of optimizing cancer outcomes in North Carolina.
A piece of history (and research) goes up
Stephanie Crayton of UNC Health Care's News Team shares her thoughts, in words and video, after witnessing the final launch of Space Shuttle Atlantis. On board the shuttle were a group of 30 mice being sent into space as part of a UNC-led study of an experimental treatment for bone loss.
UNC tapped to lead national effort to find a cure for AIDS
Researchers at the University of North Carolina at Chapel Hill have been awarded a $32 million, five-year federal grant to develop ways to cure people with HIV by purging the virus hiding in the immune systems of patients taking antiretroviral therapy. Tackling this latent virus is considered key to a cure for AIDS.
When cystic fibrosis patients grow up
In the 1950s, children diagnosed with cystic fibrosis usually died before they reached school age. Thanks to improved treatments, many patients now survive for decades, changing the ways that their doctors care for them.
real doctors, real people - Ian Udell
Dr. Ian Udell, a resident in urologic surgery at UNC Hospitals, is also a highly accomplished wakeboarder who is sponsored by O'Brien Watersports.
Channing Der and Yue Xiong receive 2011 Battle Distinguished Cancer Research Award
The Battle Distinguished Cancer Research Award, established in 2007 by the Battle Foundation of Rocky Mount, recognizes exceptional cancer research at the UNC School of Medicine and comes with a $25,000 prize for each awardee.
As HIV treatment improves, 'trial effect' is diminished, new study suggests
A new study by investigators from the University of North Carolina at Chapel Hill School of Medicine has confirmed the existence of a “trial effect” in clinical trials for treatment of HIV and also shows that effect has diminished over time.
A second chance for Jakeina
UNC heart surgeon Dr. Andy Kiser reflects on the remarkable story of one of his patients, Jakeina Sutton of Rose Hill, N.C., a 16-year-old who recently received a heart and kidney transplant. For Jakeina, this was her second heart transplant.
Family House Diaries: Cancer Diagnosis Inspires the Artist Within
Ann Hartline, a former cardiac nurse from Asheville, N.C., credits her breast cancer diagnosis with inspiring her to take up painting farm animals and landscapes, playing the ukulele and learning to fly fish.
New findings from University of North Carolina-led HIV prevention study, HPTN 052
UNC researchers presented detailed data from the landmark HIV Prevention Trials Network (HPTN) 052 study today at the 6th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention.
Mothers with breastfeeding difficulties more likely to suffer postpartum depression
A UNC study finds that women who have breastfeeding difficulties in the first two weeks after giving birth are more likely to suffer postpartum depression two months later compared to women without such difficulties.
UNC receives NIH grant to develop and test new drugs to block HIV infection
Scientists at the University of North Carolina at Chapel Hill schools of medicine and pharmacy have been awarded a $3 million federal grant to develop and test a new generation of treatments aimed at preventing sexual transmission of HIV to uninfected individuals. This remains the most common cause of HIV infection worldwide.
UNC Health Care wins Excellence in Workplace Tobacco Control Award
Four years after implementing a tobacco free policy on its campus and facilities, UNC Health Care is proud to announce that it is one of nine winners of the 2011 American Cancer Society Excellence in Workplace Tobacco Control Award.
Ann Hartline: Cancer isn't all she is
Justin Cook, the videographer behind this month's Family House Diaries story, shares his thoughts about the patient featured in his video.
Hospital-based clinic update for BCBSNC members
Beginning Aug. 1, seventeen UNC clinics will no longer be categorized as “hospital-based” for most with Blue Cross and Blue Shield of North Carolina (BCBSNC). UNC Health Care and BCBSNC have collaborated to make routine visits and services at newly designated independent UNC clinics more affordable and easier to access for BCBSNC members.
Clinical trial of molecular therapy for muscular dystrophy yields significant positive results
A molecular technique originally developed at the University of North Carolina at Chapel Hill has taken one step closer to becoming a treatment for the devastating genetic disease Duchenne muscular dystrophy.
UNC researchers identify seventh and eighth bases of DNA
For decades, scientists have known that DNA consists of four basic units -- adenine, guanine, thymine and cytosine. In recent history, scientists have expanded that list from four to six. Now researchers from the UNC School of Medicine have discovered the seventh and eighth bases of DNA.
Jacobson receives award for his contributions to the field of fluorescence
Ken Jacobson, PhD, Kenan Professor of Cell and Developmental Biology in the UNC School of Medicine, received the Gregorio Weber Award for Excellence in Fluorescence Theory and Applications at the annual meeting of the Biophysical Society in Baltimore, Md.
Male circumcision lowers prevalence of penile precancerous lesions among African men
A UNC-led international study shows that among Kenyan men, circumcision is associated with a lower prevalence of human papillomavirus-associated precancerous lesions of the penis.
